


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 15 Oct 2008
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in Finland
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in Finland
HSMN NewsFeed - 14 Oct 2008
St. Jude Medical Announces U.S. and European Approval of Angio-Seal Evolution Vascular Closure Device
St. Jude Medical Announces U.S. and European Approval of Angio-Seal Evolution Vascular Closure Device
HSMN NewsFeed - 10 Oct 2008
TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System
TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System
HSMN NewsFeed - 7 Oct 2008
Eden Spine Receives CE Mark for its Nonfusion Wellex(TM) Interspinous Process Medical Device
Eden Spine Receives CE Mark for its Nonfusion Wellex(TM) Interspinous Process Medical Device
HSMN NewsFeed - 25 Sep 2008
Acusphere, Inc. Appoints Michael Slater SVP Regulatory Affairs and Operations Replacing Dennis Bucceri
Acusphere, Inc. Appoints Michael Slater SVP Regulatory Affairs and Operations Replacing Dennis Bucceri
HSMN NewsFeed - 24 Sep 2008
Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years
Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years
HSMN NewsFeed - 22 Sep 2008
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in Denmark
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in Denmark
HSMN NewsFeed - 19 Sep 2008
Syneron Receives European CE Mark for Versatile Matrix RF(TM) Fractional Ablative Applicator
Syneron Receives European CE Mark for Versatile Matrix RF(TM) Fractional Ablative Applicator
HSMN NewsFeed - 10 Sep 2008
StemCor Systems Receives CE Mark for MarrowMiner(TM) System for Bone Marrow Collection
StemCor Systems Receives CE Mark for MarrowMiner(TM) System for Bone Marrow Collection
HSMN NewsFeed - 9 Sep 2008
Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial
Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial
HSMN NewsFeed - 8 Sep 2008
VELCADE(R) (Black Triangle Drug) (bortezomib) Approved For Previously Untreated Multiple Myeloma
VELCADE(R) (Black Triangle Drug) (bortezomib) Approved For Previously Untreated Multiple Myeloma
HSMN NewsFeed - 8 Sep 2008
Basilea's Toctino(R) (alitretinoin) receives first national marketing authorization in the UK
Basilea's Toctino(R) (alitretinoin) receives first national marketing authorization in the UK
HSMN NewsFeed - 26 Aug 2008
Elekta Receives CE Mark Clearance for 'Everyday Radiation Therapy' Accelerator, Elekta Compact
Elekta Receives CE Mark Clearance for 'Everyday Radiation Therapy' Accelerator, Elekta Compact
HSMN NewsFeed - 25 Aug 2008
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
HSMN NewsFeed - 22 Aug 2008
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
